CDK4 and breast cancer: FlowJo cell cycle raw data are presented in Supplementary Fig. S3A and B. These results suggest that overexpression of PEG10 promotes CDK4/6 inhibitor resistance in breast cancer cells by preventing G1 arrest of the cell cycle.